Guangzhou, China

Guangqiang Zhou


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Innovations by Guangqiang Zhou

Introduction

Guangqiang Zhou is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrimidine derivatives. His research focuses on enhancing drug development processes, which is crucial for the advancement of medical treatments.

Latest Patents

One of Guangqiang Zhou's key patents is titled "Dominant salt forms of pyrimidine derivatives, and crystal forms thereof." This patent discloses sodium salts of pyrimidine derivatives along with a series of crystal forms. These crystal forms exhibit excellent druggability, including stability, fluidity, and compressibility. This innovation provides a variety of options for active pharmaceutical ingredients (APIs) that can be utilized in subsequent drug product development.

Career Highlights

Guangqiang Zhou is currently associated with Guangdong Raynovent Biotech Co., Ltd. His work at this company emphasizes the importance of research and development in the pharmaceutical industry. His contributions have been instrumental in advancing the understanding and application of pyrimidine derivatives in drug formulation.

Collaborations

Guangqiang Zhou has collaborated with notable colleagues, including Xiaoxin Chen and Chengwu Liu. These collaborations have fostered a productive research environment, leading to innovative solutions in drug development.

Conclusion

Guangqiang Zhou's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations highlight the importance of research in developing effective medical treatments. His contributions continue to shape the future of drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…